Monkeypox outbreak—Nine states, May 2022: Weekly/June 10, 2022/71 (23); 764–769 FS Minhaj, YP Ogale, F Whitehill, J Schultz, M Foote, W Davidson, ... American Journal of Transplantation 22 (8), 2104-2110, 2022 | 324 | 2022 |
Shedding of infectious SARS-CoV-2 despite vaccination KK Riemersma, LA Haddock III, NA Wilson, N Minor, J Eickhoff, ... PLoS Pathogens 18 (9), e1010876, 2022 | 132 | 2022 |
Comparison of home antigen testing with RT-PCR and viral culture during the course of SARS-CoV-2 infection VT Chu, NG Schwartz, MAP Donnelly, MR Chuey, R Soto, AR Yousaf, ... JAMA internal medicine 182 (7), 701-709, 2022 | 117 | 2022 |
Prevention of influenza hospitalization among adults in the United States, 2015–2016: results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) JM Ferdinands, M Gaglani, ET Martin, D Middleton, AS Monto, K Murthy, ... The Journal of infectious diseases 220 (8), 1265-1275, 2019 | 73 | 2019 |
Influenza vaccine effectiveness against hospitalization in fully and partially vaccinated children in Israel: 2015–2016, 2016–2017, and 2017–2018 HE Segaloff, M Leventer-Roberts, D Riesel, RE Malosh, BS Feldman, ... Clinical Infectious Diseases 69 (12), 2153-2161, 2019 | 35 | 2019 |
Rapid spread of SARS-CoV-2 in a state prison after introduction by newly transferred incarcerated persons—Wisconsin, August 14–October 22, 2020 RB Hershow MMWR. Morbidity and mortality weekly report 70, 2021 | 34 | 2021 |
Performance of repeat BinaxNOW severe acute respiratory syndrome coronavirus 2 antigen testing in a community setting, Wisconsin, November 2020–December 2020 MM Shah, PP Salvatore, L Ford, E Kamitani, MJ Whaley, K Mitchell, ... Clinical Infectious Diseases 73 (Supplement_1), S54-S57, 2021 | 33 | 2021 |
Interventions to disrupt coronavirus disease transmission at a university, Wisconsin, USA, August–October 2020 DW Currie, GK Moreno, MJ Delahoy, IW Pray, A Jovaag, KM Braun, ... Emerging Infectious Diseases 27 (11), 2776, 2021 | 30 | 2021 |
The impact of obesity and timely antiviral administration on severe influenza outcomes among hospitalized adults HE Segaloff, R Evans, S Arshad, MJ Zervos, C Archer, KS Kaye, ET Martin Journal of Medical Virology 90 (2), 212-218, 2018 | 28 | 2018 |
Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014–2015 and 2015–2016 HE Segaloff, JG Petrie, RE Malosh, CK Cheng, EJ McSpadden, ... Epidemiology & Infection 146 (11), 1350-1358, 2018 | 27 | 2018 |
Patterns of influenza vaccination and vaccine effectiveness among young US children who receive outpatient care for acute respiratory tract illness JR Chung, B Flannery, M Gaglani, ME Smith, EC Reis, RW Hickey, ... JAMA pediatrics 174 (7), 705-713, 2020 | 26 | 2020 |
Co-circulation of influenza A (H1N1) pdm09 and influenza A (H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019 H Segaloff, A Melidou, C Adlhoch, D Pereyaslov, E Robesyn, P Penttinen, ... Eurosurveillance 24 (9), 1900125, 2019 | 22 | 2019 |
Household transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Alpha variant—United States, 2021 MAP Donnelly, MR Chuey, R Soto, NG Schwartz, VT Chu, SL Konkle, ... Clinical Infectious Diseases 75 (1), e122-e132, 2022 | 18 | 2022 |
Antigen test performance among children and adults at a SARS-CoV-2 community testing site L Ford, MJ Whaley, MM Shah, PP Salvatore, HE Segaloff, A Delaney, ... Journal of the Pediatric Infectious Diseases Society 10 (12), 1052-1061, 2021 | 18 | 2021 |
Severe acute respiratory syndrome coronavirus 2 transmission in intercollegiate athletics not fully mitigated with daily antigen testing GK Moreno, KM Braun, IW Pray, HE Segaloff, A Lim, K Poulsen, J Meiman, ... Clinical Infectious Diseases 73 (Supplement_1), S45-S53, 2021 | 17 | 2021 |
Performance of repeat BinaxNOW SARS-CoV-2 antigen testing in a community setting, Wisconsin, November-December 2020 MM Shah, PP Salvatore, L Ford, E Kamitani, MJ Whaley, K Mitchell, ... medRxiv, 2021.04. 05.21254834, 2021 | 17 | 2021 |
SARS-CoV-2 transmission in intercollegiate athletics not fully mitigated with daily antigen testing GK Moreno, KM Braun, IW Pray, HE Segaloff, A Lim, K Poulson, J Meiman, ... medRxiv, 2021 | 14 | 2021 |
Association of shared living spaces and COVID-19 in university students, Wisconsin, USA, 2020 JP Bigouette, L Ford, HE Segaloff, K Langolf, J Kahrs, T Zochert, JE Tate, ... Emerging Infectious Diseases 27 (11), 2882, 2021 | 13 | 2021 |
Shedding of Infectious SARS-CoV-2 Despite Vaccination [Internet]. Infectious Diseases (except HIV/AIDS); 2021 [zitiert 2021 Okt 13] KK Riemersma, BE Grogan, A Kita-Yarbro, PJ Halfmann, HE Segaloff, ... | 13 | |
Risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and presence of anti–SARS-CoV-2 antibodies among university student dormitory residents … HE Segaloff, D Cole, HG Rosenblum, CC Lee, CN Morgan, P Remington, ... Open forum infectious diseases 8 (9), ofab405, 2021 | 12 | 2021 |